Testing smart socks to measure walking and balance in Parkinson's disease
Checks how well smart socks measure walking and balance in people with Parkinson's.
Plain-language title generated from the registry record
Registry title: Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
Key facts
- Where
- Newcastle upon Tyne, United KingdomSee the site
Where in United Kingdom
- Northumbria UniversityNewcastle upon Tyne, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Northumbria University
- Trial code
- NCT07281755
- Record updated
- 12 February 2026
- Original description
The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.Read full original descriptionShow less
Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.
Inclusion: Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria; Hoehn \& Yahr stages I-III; Able to attend Northumbria University, Newcastle Upon Tyne for study visits; Able to walk and stand unassisted for a minimum of 2-minutes.
Exclusion: History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.); Montreal Cognitive Assessment (MoCA) score < 21; Injury to the lower extremities within the past 6-weeks.